MiR-219-5p Inhibits the Growth and Metastasis of Malignant Melanoma by Targeting BCL-2

被引:29
|
作者
Long, Jianwen [1 ,2 ,3 ]
Menggen, Qiqige [4 ]
Wuren, Qimige [4 ]
Shi, Quan [2 ,3 ]
Pi, Xianming [2 ,3 ]
机构
[1] Hubei Univ Chinese Med, Sch Clin Med 1, Dept Dermatol, Wuhan, Hubei, Peoples R China
[2] Hubei Prov Hosp Tradit Chinese Med, Dept Dermatol, Wuhan, Peoples R China
[3] Hubei Prov Acad Tradit Chinese Med, Dept Dermatol, Wuhan, Hubei, Peoples R China
[4] Mongolian Med Hosp, Dept Dermatol, Bortala Mongol Autonomou, Peoples R China
关键词
CANCER; IMMUNOTHERAPY; EXPRESSION; MICRORNAS; INVASION; ROLES; CELLS;
D O I
10.1155/2017/9032502
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Malignant melanoma is a very dangerous tumor which is resistant to conventional therapy. MicroRNA exerts a vital function in promoting or inhibiting tumor development. The research has investigated the expression and function of miR-219-5p inmelanoma. As a result, miR-219-5p expression was distinctly reduced inmelanoma tissues and cell lines and was negatively correlated with Bcl-2 protein level in melanoma. Patients with low miR-219-5p level represented obviously a low overall survival in comparison with patients with high miR-219-5p level. The upregulation of miR-219-5p inhibited melanoma growth and metastasis and strengthened melanoma cells chemosensitivity by targeting Bcl-2. Therefore, the modulation of miR-219-5p expression may be a novel treatment strategy in melanoma.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2
    Feng Xing
    Zhijiao Song
    Yuanying He
    Biological Research, 51
  • [2] MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2
    Huang, W-T
    Zhang, H.
    Jin, Z.
    Li, K.
    Hu, C.
    Li, M-L
    Situ, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (09) : 4710 - 4718
  • [3] miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma
    Rao, Soumya Alige Mahabala
    Arimappamagan, Arivazhagan
    Pandey, Paritosh
    Santosh, Vani
    Hegde, Alangar Sathyaranjandas
    Chandramouli, Bangalore Ashwathnarayanara
    Somasundaram, Kumaravel
    PLOS ONE, 2013, 8 (05):
  • [4] MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3
    Huang, Na
    Lin, Jing
    Ruan, Jian
    Su, Ning
    Qing, Ruzhai
    Liu, Feiye
    He, Benfu
    Lv, Chengwei
    Zheng, Dayong
    Luo, Rongcheng
    FEBS LETTERS, 2012, 586 (06) : 884 - 891
  • [5] miR-219-5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor α
    Huang, Chen
    Cai, Zhaogeng
    Huang, Mingzhu
    Mao, Chaoming
    Zhang, Qifa
    Lin, Yi
    Zhang, Xiaomei
    Tang, Bi
    Chen, Yuqing
    Wang, Xiaojing
    Qian, Zhongqing
    Ye, Lei
    Peng, Yongde
    Xu, Huanbai
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : E204 - E213
  • [6] MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2 (Publication with Expression of Concern. See vol. 43, 2023)
    Xing, Feng
    Song, Zhijiao
    He, Yuanying
    BIOLOGICAL RESEARCH, 2018, 51
  • [7] miR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2
    Zhang, Z. R.
    Yang, N.
    NEOPLASMA, 2020, 67 (04) : 813 - 824
  • [8] miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin
    Wang, Quhui
    Zhu, Lirong
    Jiang, Yasu
    Xu, Junfei
    Wang, Feiran
    He, Zhixian
    ONCOLOGY LETTERS, 2017, 13 (03) : 1319 - 1324
  • [9] miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence
    Wei, Wei
    Zhang, Qiuhang
    Wang, Zhenlin
    Yan, Bo
    Feng, Yanjun
    Li, Pu
    ONCOLOGY LETTERS, 2016, 12 (06) : 4568 - 4576
  • [10] miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI
    Song, Kai-Bin
    Liu, Wen-Juan
    Jia, Shen-Shan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (09): : 2957 - 2965